Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Finally, our strong balance sheet gives us flexibility to pursue strategic acquisitions while maintaining multiple options to create shareholder value |
| So that's why I spend so much time talking about eVerest and eVoS because those are two new flagship technologies, which have been eagerly embraced by the customers and we think they are going to drive real share gain for the company over the next three to five years |
| We delivered record cash flow of $85 million in the fourth quarter |
| Over the full year, we delivered record cash flow of $213 million by maintaining good profitability and reducing inventory |
| So we're very well positioned going into this year |
| So we think building these geographical ecosystems is a good thing for the industry, and it will be a good thing for us |
| In the semiconductor market, we enjoyed record sales of high-voltage products in 2023 |
| We also achieved record revenue in our service business due to a growing installed base of subsystems in a broader portfolio of services |
| In our other markets, we achieved yearly revenue in the industrial medical space and successfully ramped a major hyperscale product to high volume |
| We achieved a record number of design wins in the semiconductor, industrial and medical markets in 2023, exciting new products, a motivated sales team and enhanced go-to-market strategies enabled these wins, which are a critical leading indicator of future growth |
| We set a record revenue performance in I&M |
| Ultimately, we expect this consolidation to improve manufacturing efficiency and execution, and it's a key part of our effort to move margins above 40% in 2025 as markets recover |
| Fourth quarter semiconductor revenue increased 3% sequentially to $191 million, a bit better than expected |
| In the fourth quarter, shipments of eVerest and eVoS, 80 units increased sharply, and we are maintaining that strong pace in the current quarter |
| Customers are eager to evaluate the new technologies, which offer significant yield and throughput advantages for advanced process nodes |
| But the underlying setup for gross margin, we feel is very good as we go forward |
| We think all of that positions us well to see really nice earnings growth as we go into 2025 |
| And that's why on similar revenue levels in the fourth quarter to what we had this year in the fourth quarter, we ought to be doing roughly 200 basis points better or, as I said, 250 to 300 basis points better than where we're starting the year |
| Addressing the need for higher power in a smaller form factor, NeoPower offers best-in-class power density to our industrial and medical customers |
| Investments in the channel and our digital platform are helping to broaden our customer base and are expected to drive future market share gains in the industrial medical space |
| We are doing a better job communicating our value proposition to customers across all of our markets |
| We are very well positioned for the node transitions that are going to transpire starting in the second half of this year |
| And at that level, we ought to be able to deliver gross margins 250 to 300 basis points higher than Q1 |
| The other thing that's telling us is that the second half will better than the first half |
| So we feel pretty good about that when you look out in time because of the work we're doing now, the setup of things we can control in terms of managing our cost structure, getting that where we'd like it, getting the foundation for gross margin in place, the investments in new products and opportunity to gain share of the investments in channel |
| Positioning us to reach our gross margin goal of over 40% and to deliver higher earnings than our prior peak as markets recover in 2025 |
| And that's better than what we've been modeling up to now where we thought we'd take -- need to get to the mid-to high $400 million range |
| But I think the other thing is the improvements that we're making in the factories and efficiency from a cost perspective and even a little bit of mix is we're getting some product benefit from a sole source perspective, sole source mix towards the end of the year |
| Good execution throughout the organization resulted in Q4 earnings of $1.24 per share at the higher end of our guidance range |
| And I think generally, the market views 25 as a pretty strong year, which we'll benefit from irregardless of our new products, the channel investments and everything else |
| Statement |
|---|
| Base center computing revenue of $63 million, down 8% sequentially |
| Fourth quarter revenue from data center computing customers totaled $63 million, down 8% sequentially |
| Fourth quarter gross margin was 35.7%, down 40 basis points sequentially, mainly on less favorable revenue mix |
| In the industrial medical market, fourth quarter revenue decreased 6% sequentially to $109 million |
| Operating margin for the quarter was 12.3% down slightly from last quarter on lower revenue |
| We expect data center computing revenues to be down mid-20% sequentially |
| Softening demand in the trailing edge part of the semiconductor market, sluggish demand in the industrial medical market an ongoing weakness in the enterprise computing market are all contributing to a sequentially lower first quarter |
| As digestion of large programs we react [ph] in the second half of 2023 and ongoing weakness in the enterprise market impact revenues in the first half |
| Sales into the industrial and medical market were $109 million, down 6% sequentially |
| We expect Industrial and Medical revenues in the first quarter to decline mid-teens sequentially as customers and distributors are very cautious in the near term |
| In 2023, we delivered revenue of $1.66 billion, down 10% year-over-year |
| Operating expenses were $95 million, down 2.5% from last quarter and below our plan |
| Obviously, the environment, the last 1.5 years has been challenging with parts that's abated where you're now in a bit of a market subpoint |
| Even though our semiconductor revenue was down about 20% in 2023 |
| Looking forward, we see broad-based market weakness in the first half of 2024, followed by second half improvement and further strengthening in 2025 |
| As we began to see in Q3, increasing macroeconomic weakness impacted overall demand in Q4 partially offset by revenue from design wins we secured in prior quarters |
| Steve, most industrial companies we cover are saying what you just did, which is weak first half return to normal in the back half |
| Obviously, they started six months -- a year ago, they were in the down 20s and then they came in from that to down 10s and 15s, and I'm just wondering why with market conditions is still difficult, but seemingly less difficult |
| And quite frankly, that's been a bit of a challenge |
| In fact, things we've done, we think are actually protecting gross margins at 35%, which is only down 70 basis on the drop in volume we've seen |
Please consider a small donation if you think this website provides you with relevant information